The Apollo Stent System is an innovative solution designed to provide exceptional support and stability during vascular interventions. This stent system is engineered to deliver superior performance with a focus on safety, efficacy, and ease of use.
APOLLO™
The Apollo Stent System is crafted to offer robust support, ensuring the vessel remains open and stable. This is particularly crucial in maintaining vessel patency and preventing restenosis.
Strong Supportability
High Biocompatibility
Constructed from materials that are highly compatible with the human body, the Apollo Stent minimizes the risk of adverse reactions, promoting faster healing and better long-term outcomes.
Minimize stent axial foreshortening
The Apollo Stent features an “n” shape connector designed to minimize stent axial foreshortening and contribute to excellent flexibility.
Enhanced Radiopacity
The Apollo Stent is equipped with radiopaque markers that provide excellent visibility under fluoroscopy. These markers facilitate accurate positioning and deployment, allowing physicians to monitor the stent’s placement in real-time and make necessary adjustments during the procedure.
Flexible Design
The flexible structure of the Apollo Stent adapts to the natural contours of the vessel, ensuring a snug fit and optimal performance even in tortuous anatomies.
Ease of Use
The delivery system of the Apollo Stent is user-friendly, facilitating smooth and efficient deployment. This ease of use enhances procedural efficiency and reduces overall operation time.
Product Specification
APOLLO™ Clinical Trials
Apollo vs. Wingspan: Stenting for Symptomatic Intracranial Arterial Stenosis
1-year outcomes of Apollo balloon-mounted stents versus Wingspan self-expanding stents in treating symptomatic intracranial arterial stenosis in a Chinese population, focusing on stroke recurrence and restenosis rates.
Balloon-Mounted vs. Self-Expanding Stents for Symptomatic Intracranial Vertebrobasilar Artery Stenosis Combined with Poor Collaterals
effectiveness of balloon-mounted versus self-expanding stents for patients with symptomatic vertebrobasilar artery stenosis and poor collateral circulation, evaluating outcomes such as stroke prevention and procedural success.
Thirty-Day Outcome of a Multicenter Registry Study of Stenting for Symptomatic Intracranial Artery Stenosis
30-day safety and efficacy of stenting for severe symptomatic intracranial artery stenosis in China, comparing outcomes between balloon-mounted and self-expanding stents.
Balloon-Mounted vs. Self-Expanding Stent Outcomes in Symptomatic Middle Cerebral Artery Stenosis Combined with Poor Collaterals
compare balloon-mounted and self-expanding stents in treating symptomatic middle cerebral artery stenosis with poor collateral circulation, focusing on procedural success and short-term outcomes.